News and blogs
175 results found.
Blood Cancer UK have renewed their partnership with RareCan
Blood Cancer UK have renewed their partnership with RareCan, a digital health company. This could give people an opportunity to help researchers.
A new dawn for clinical trials
A new dawn for clinical trials to get us to a place where no lives are lost to blood cancer
Targeting tumour stroma could improve immunotherapy response in lymphoma
Blood Cancer UK researchers at King's College London have shown how specific cells known as ‘fibroblast cells’ in lymphoma tumours suppress the body’s immune cells and immunotherapy treatment.
Blood cancer drug ruxolitinib gives better outcomes than those on best-available existing medication
The drug, ruxolitinib, has been found to be better at treating the blood cancer - polycythaemia vera (PV) than the best currently available treatment.
Using motixafortide to treat multiple myeloma
New research suggests that motixafortide improves stem cell transplants for those with multiple myeloma.
How research could put an end to the fear of cancer returning
How research could put an end to the fear of cancer returning
Blood Cancer UK fund new research
Blood Cancer UK are funding 16 new research projects worth £14 million
CAR-T cell therapy made available on NHS
Yescarta has now been made available for people with certain types of lymphoma on the NHS in England
The origins of childhood leukaemia in twins
Blood Cancer UK's research funding has led to an understanding of the origins of childhood leukaemia in twins.
New ‘universal approach’ therapy for leukaemia shows promise during world-first trial
Blood Cancer UK was proud to fund the lab studies that directly led to this life-changing trial which could broaden the number of people who benefit from this type of therapy in future.
Paxlovid rebound - what we know
Paxlovid rebound is when people recover from covid-19 after taking a course of Paxlovid tablets, but then the infection seems to come back. Find out what this means for people offered treatment with Paxlovid.
Evusheld available in the UK to buy privately
Evusheld is available privately in the UK. Here’s what we know about how to access it.
Health inequalities: how does stress change our bodies?
Read our blog about how social factors are more likely to impact certain groups.
Dr Sidney Farber's story
Read about Dr Sidney Farber who discovered the role folic acid played in the creation of leukaemia cells and achieved the first clinical remission of leukaemia in children by using a chemical anti agent.
What's the latest on Evusheld?
A look at the latest news on Evusheld
Five things we learned about blood cancer services from the cancer patient experience survey
Every year, NHS England asks thousands of cancer patients in England about their experiences. We've picked out five key things we think the NHS and Government should be focusing on, which we believe would save a significant number of lives.
People affected by blood cancer help decide what research we fund
For the first time at Blood Cancer UK, this year a group of 16 people affected by blood cancer reviewed all applications received by us for research funding.
Evusheld – is it effective?
In this blog, we talk about what the latest research is telling us about how effective Evusheld is.
Blood Cancer UK's research strategy
Since Blood Cancer UK was formed in 1960, it has invested over £500m in lifesaving blood cancer research.
This is Blood Cancer
Saturday 28 May is World Blood Cancer Day and we’re delighted to be able to share this new, hour-long documentary including films from Blood Cancer UK and other partners.
